Need help?
<- Back

Comments (280)

  • nik_s
    I think the layman's perception of the increase in survival (~13 months versus ~6 months) will make this look underwhelming. Nevertheless, it's important to remember that the incentives for clinical trials is to only include very late-stage patients who have exhausted all other options (faster trials, smaller sample sizes, surrogate endpoints, a shot at accelerated approval, ...). The fact that a treatment shows promise for these patients that are often in very poor health and considered "hopeless" by today's medicine is exceedingly rare, and the signal from this trial is indeed strong.The (somewhat reasonable) hope is that patients 1. with earlier forms of pancreatic cancer (non-metastatic) 2. that can undergo surgery 3. together with a (neo)adjuvant treatment with these kras inhibitors, will end up having a much lower recurrence rate and a chance for a long, healthy life.I think this is genuinely good news worth celebrating!
  • mft_
    For once, this isn’t hyperbole. Metastatic pancreatic cancer hasn’t had a meaningful new treatment in literally decades - it’s been brutal chemotherapy or slightly less brutal chemotherapy.The new generation of KRAS inhibitors, of which daraxonrasib is just the first to make it to approval, is genuinely a practice-changing breakthrough.It won’t cure people with metastatic disease, but it will help a lot live better lives for longer.
  • dang
    In case others are wondering, it looks like this is a different story than this recent one:Pancreatic cancer halted by virus injection in three patients - https://news.ycombinator.com/item?id=50563066 - Nov 2026 (157 comments)
  • responder41
    RAS is a (class of) proteins in the membrane of your cells that are important in telling cells when it is time to grow. These proteins cycle between an "active" state that stimulates growth and an "inactive" state that doesn't. An extremely common genetic mutation that happens as a person develops cancer causes some of these cells to start making RAS proteins that do not correctly switch back to the "inactive" state. The cells with these mutations then grow and divide very rapidly and can become a tumor. Daraxonrasib works by binding the active state RAS proteins and preventing them from signalling and triggering growth. This can help prevent the tumors from growing further and potentially even shrink them as they are attacked by the immune system or other medication.(I'm not an expert, just a fan of knowing how things work, anyone can correct me if they know better)
  • tptacek
    People who pay a lot of attention to US news might know this as the therapy former senator and UF president Ben Sasse is taking.
  • shmoil
  • brooke2k
    Does the -ib medication suffix have meaning? I know -ab medications like Benralizumab, Canakinumab, etc are monoclonal antibodies. The only -ib I can remember other than this new one is Imatinib, which is also a cancer treatment, so maybe it's to do with cancer?
  • mmaunder
    I’m not in biotech so I don’t understand how approvals work, but it sounds like it’s already being used and that patients develop a resistance to it and it stops working. Perhaps someone in the field can help explain the dissonance between these articles.https://www.nytimes.com/2026/09/30/science/pancreatic-cancer...
  • charlieyu1
    I do hope to see more progress on medicine with AI.If we can prove GRH with AI we really should be able to cure cancer.
  • nozzlegear
    My former boss, one of the nicest, kindest and most jovial guys I've ever known, had pancreatic cancer. He quite literally wasted away before our eyes and died within a year. He was a big, round guy in life, but lying in his casket, it was like someone had let all the air out of a balloon. There wasn't anything left of him.Pancreatic cancer is nasty (most cancers are), but the recent breakthroughs make me hopeful that we'll one day see a world where it won't be so devastating.
  • fadulastripe
    We can hope that the treatment will be accessible to the most still as it's been dicovered in the US
  • anon
    undefined
  • inglor_cz
    Former PM of Czechia, Topolánek, suffers from pancreatic cancer and is very open about it in the media.Accidentally I know him personally, we lived in the same city. A tough guy, though not an angel; anyway, politics aside, I am glad that he is still alive and that he did a huge job opening the debate on pancreatic cancer and its possible prevention or early treatment.He is also a frequent guest in podcasts and I noticed lately that his face looks really weird, as if scalded. I believe this is a side-effect of daraxonrasib. He mentioned something about experimental treatment.
  • sooraj_sj
    yes this is worse kind of cancer with no much tretament , would have saved steve jobs
  • ourmandave
    It would be amazing to live in a time we could say, "remember when cancer was a thing?"You know, like we do now with measles.
  • sudohalt
    Great news, pharma and biotech is one of the last frontiers that Anthropic can't steal results from and claim it as their own win. If Ant could they would have stole the drug and claimed that they discovered a cure, but since trials take years there is no "quick win" for them.
  • pvaldes
    And the study from Barbacid, Liaki y Guerra is not mentioned at all, after being retracted by a conflict of interests.
  • elendilm
    The article conflates tumor with cancer.Does the pill address both pancreatic cancer and tumor or just one of them?
  • SilentM68
    Hope this is the start of a new age of inexpensive cures & treatments that will be available to everyone, regardless of financial status :)
  • LightBug1
    FUCK YES. Sorry, just good to read, what seems to be, real progress.
  • thr0waway001
    Steve Jobs would've funded the shit outta this.
  • xqcgrek2
    We'll look back at the era of chemotherapy and surgery as barbarism
  • ccie13192
    [flagged]
  • Prosper_nwo
    [flagged]
  • breck
    [dead]
  • aaron695
    [dead]
  • rookienumbers30
    Rasonque (daraxonrasib$480,000/year price tag44% severe side effect ratea few months extra survivalI call bs on the "biggest breakthrough in decades" unless this is referring to the manufacturer's bottom line.
  • hn_submit
    There's only one sure treatment for all types of cancers and that is gene repair. But pharmaceutical companies aren't interested because repairing genes cannot be patented. The future is being delayed because of corporate interests.